[go: up one dir, main page]

NO20054885D0 - 3-alkylidenhydrazino substituerte heteroarylforbindelser som trombopoietin reseptor aktivator - Google Patents

3-alkylidenhydrazino substituerte heteroarylforbindelser som trombopoietin reseptor aktivator

Info

Publication number
NO20054885D0
NO20054885D0 NO20054885A NO20054885A NO20054885D0 NO 20054885 D0 NO20054885 D0 NO 20054885D0 NO 20054885 A NO20054885 A NO 20054885A NO 20054885 A NO20054885 A NO 20054885A NO 20054885 D0 NO20054885 D0 NO 20054885D0
Authority
NO
Norway
Prior art keywords
substituted heteroaryl
receptor activator
heteroaryl compounds
thrombopoietin receptor
alkylidene
Prior art date
Application number
NO20054885A
Other languages
English (en)
Other versions
NO20054885L (no
NO334084B1 (no
Inventor
Takanori Nakamura
Kazufumi Yanagihara
Norihisa Ishiwata
Shingo Owada
Shunsuke Iwamoto
Katsuaki Miyaji
Yutaka Hirokawa
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of NO20054885D0 publication Critical patent/NO20054885D0/no
Publication of NO20054885L publication Critical patent/NO20054885L/no
Publication of NO334084B1 publication Critical patent/NO334084B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20054885A 2003-06-06 2005-10-21 3-alkylidenhydrazino substituerte heteroarylforbindelser, medikamenter omfattende slike forbindelser, slike forbindelser som medikamenter og slike forbindelser som blodplateøkende middel NO334084B1 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2003161987 2003-06-06
JP2003330627 2003-09-22
JP2003404635 2003-12-03
JP2004094931 2004-03-29
PCT/JP2004/008165 WO2004108683A1 (en) 2003-06-06 2004-06-04 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators

Publications (3)

Publication Number Publication Date
NO20054885D0 true NO20054885D0 (no) 2005-10-21
NO20054885L NO20054885L (no) 2005-12-28
NO334084B1 NO334084B1 (no) 2013-12-09

Family

ID=33514809

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054885A NO334084B1 (no) 2003-06-06 2005-10-21 3-alkylidenhydrazino substituerte heteroarylforbindelser, medikamenter omfattende slike forbindelser, slike forbindelser som medikamenter og slike forbindelser som blodplateøkende middel

Country Status (17)

Country Link
US (5) US7351841B2 (no)
EP (1) EP1636192B9 (no)
JP (2) JP4386072B2 (no)
KR (1) KR101211975B1 (no)
AU (1) AU2004245401B2 (no)
CA (1) CA2520115C (no)
DK (1) DK1636192T3 (no)
ES (1) ES2445029T3 (no)
IL (1) IL172374A (no)
MX (1) MXPA05013209A (no)
NO (1) NO334084B1 (no)
NZ (1) NZ542495A (no)
PL (1) PL1636192T3 (no)
PT (1) PT1636192E (no)
TW (1) TWI395739B (no)
UA (1) UA82695C2 (no)
WO (1) WO2004108683A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA82695C2 (uk) * 2003-06-06 2008-05-12 Нисан Кемикал Индастриз, Лтд. Гетероароматичні сполуки як активатори рецептора тромбопоетину
FR2866886B1 (fr) * 2004-02-26 2007-08-31 Sanofi Synthelabo Derives d'aryl-et d'heteroaryl-akylcarbamates, leur preparation et leur application en therapeutique
WO2005118551A2 (en) * 2004-05-28 2005-12-15 Ligand Pharmaceuticals Inc. Thrombopoietin activity modulating compounds and methods
AU2005299720B2 (en) * 2004-10-25 2010-02-04 Ligand Pharmaceuticals Incorporated Thrombopoietin activity modulating compounds and methods
RU2395505C2 (ru) * 2004-12-08 2010-07-27 Ниссан Кемикал Индастриз, ЛТД 3-этилиденгидразино-замещенные гетероциклические соединения в качестве активаторов рецептора тромбопоэтина
TW200633998A (en) * 2004-12-08 2006-10-01 Nissan Chemical Ind Ltd Substituted heterocyclic compounds and thrombopoietin receptor activators
UA89970C2 (ru) * 2004-12-08 2010-03-25 Ниссан Кемикал Индастрис, Лтд. Гетероциклические соединения и активаторы рецептора тромбопоэтина
TW200633997A (en) * 2004-12-08 2006-10-01 Nissan Chemical Ind Ltd Substituted heterocyclic compounds and thrombopoietin receptor activators
US8134013B2 (en) 2004-12-14 2012-03-13 Nissan Chemical Industries, Ltd. Amide compound and thrombopoietin receptor activator
CA2609319C (en) 2005-07-15 2014-02-04 Nissan Chemical Industries, Ltd. Thiophene compounds and thrombopoietin receptor activators
RU2424238C2 (ru) * 2005-07-15 2011-07-20 Ниссан Кемикал Индастриз, Лтд. Тиофеновые соединения и активаторы рецептора тромбопоэтина
KR101290484B1 (ko) 2005-07-20 2013-07-26 닛산 가가쿠 고교 가부시키 가이샤 피라졸 화합물 및 트롬보포이에틴 수용체 활성화제
WO2007052808A1 (ja) * 2005-11-07 2007-05-10 Nissan Chemical Industries, Ltd. ヒドラジド化合物及びトロンボポエチンレセプター活性化剤
US8093251B2 (en) 2006-06-07 2012-01-10 Nissan Chemical Industries, Ltd. Nitrogen-containing heterocyclic compounds and thrombopoietin receptor activators
US7784330B2 (en) * 2007-10-05 2010-08-31 Schlumberger Technology Corporation Viscosity measurement
JP5573161B2 (ja) * 2007-12-05 2014-08-20 日産化学工業株式会社 ヘテロ環化合物による造血幹細胞の増幅方法
JP5573160B2 (ja) * 2007-12-05 2014-08-20 日産化学工業株式会社 ヘテロ環化合物による造血幹細胞の増幅方法
EP2228435A4 (en) * 2007-12-05 2013-01-23 Nissan Chemical Ind Ltd METHOD FOR AMPLIFYING HEMATOPOIETIC STRAIN CELL USING HETEROCYCLIC COMPOUND
WO2009072635A1 (ja) 2007-12-06 2009-06-11 Nissan Chemical Industries, Ltd. ヘテロ環化合物による造血幹細胞の増幅方法
CN103360290B (zh) * 2008-02-29 2015-04-01 日产化学工业株式会社 噻吩化合物及其中间体的制造方法
EP2408306A4 (en) * 2009-03-20 2012-11-07 Alios Biopharma Inc SUBSTITUTED NUCLEOSIDE AND NUCLEOTIDE ANALOGUES
US8680150B2 (en) * 2009-05-28 2014-03-25 Ligand Pharmaceuticals, Inc. Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors
WO2010140685A1 (ja) 2009-06-04 2010-12-09 日産化学工業株式会社 ヘテロ環化合物及び造血幹細胞の増幅剤
JP5704073B2 (ja) * 2009-10-23 2015-04-22 日産化学工業株式会社 縮環へテロ環化合物及びトロンボポエチンレセプター活性化剤
BR112013005872A2 (pt) 2010-09-22 2019-09-24 Alios Biopharma Inc compostos, composição farmacêutica e respectivos usos
UA109287C2 (uk) 2010-11-02 2015-08-10 Солі органічного аміну похідних амінобензойної кислоти і спосіб їх одержання
JP2012111750A (ja) * 2010-11-02 2012-06-14 Nissan Chem Ind Ltd アミノ安息香酸誘導体の溶媒和物及びその製造方法
JP5876498B2 (ja) 2011-10-03 2016-03-02 日産化学工業株式会社 多能性幹細胞からの巨核球及び／又は血小板の製造方法
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
HK1203356A1 (en) 2012-03-22 2015-10-30 艾丽奥斯生物制药有限公司 Pharmaceutical combinations comprising a thionucleotide analog
CN103664622B (zh) * 2012-09-18 2016-01-13 浙江工业大学 Ab型羟基改性高聚物的单体及其中间体和制备方法
JP6279430B2 (ja) * 2014-08-21 2018-02-14 東芝メモリ株式会社 テンプレート、テンプレート形成方法および半導体装置の製造方法
SG11201703407UA (en) 2014-10-31 2017-05-30 Nissan Chemical Ind Ltd Ligand-binding fiber and cell culture substrate using said fiber
WO2018199797A1 (ru) * 2017-04-27 2018-11-01 Общество с ограниченной ответственностью "ОнкоТартис" Замещенные 2-метилиден-5-(фениламино)-2,3-дигидротиофен-3-оны для лечения лейкозов с транслокациями mll-гена и других онкологических заболеваний
WO2020248065A1 (en) * 2019-06-12 2020-12-17 Ontario Institute For Cancer Research (Oicr) Unsaturated heterocycloalkyl and heteroaromatic acyl hydrazone linkers, methods and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0258182A1 (en) * 1986-08-08 1988-03-02 Sandoz Ag Semicarbazones and thiosemicarbazones
ZA981934B (en) * 1997-03-10 1999-09-06 Rhone Poulenc Agrochimie Pesticidal 1-aryl-3-iminopyrazoles.
US6270345B1 (en) * 1999-10-28 2001-08-07 Dove Systems, Inc. Vane motor for dental and medical handpieces
EP1228051A1 (en) 1999-11-05 2002-08-07 SmithKline Beecham Corporation Semicarbazone derivatives and their use as thrombopoietin mimetics
US6720345B1 (en) 1999-11-05 2004-04-13 Smithkline Beecham Corporation Semicarbazone derivatives and their use as thrombopoietin mimetics
CA2436288A1 (en) * 2000-12-19 2002-06-27 Smithkline Beecham Corporation Thrombopoietin mimetics
WO2002085343A1 (en) * 2001-03-01 2002-10-31 Smithkline Beecham Corporation Thrombopoietin mimetics
EP1552828A4 (en) 2002-08-14 2007-01-24 Nissan Chemical Ind Ltd THROMBOPOIETIN RECEPTOR ACTIVATOR AND METHOD OF PRODUCTION
TWI324593B (en) 2002-10-09 2010-05-11 Nissan Chemical Ind Ltd Pyrazolone compounds and thrombopoietin receptor activator
UA82695C2 (uk) 2003-06-06 2008-05-12 Нисан Кемикал Индастриз, Лтд. Гетероароматичні сполуки як активатори рецептора тромбопоетину
RU2395505C2 (ru) * 2004-12-08 2010-07-27 Ниссан Кемикал Индастриз, ЛТД 3-этилиденгидразино-замещенные гетероциклические соединения в качестве активаторов рецептора тромбопоэтина
US8134013B2 (en) 2004-12-14 2012-03-13 Nissan Chemical Industries, Ltd. Amide compound and thrombopoietin receptor activator
JP4941301B2 (ja) 2005-04-14 2012-05-30 日産化学工業株式会社 α置換ビニルスズ化合物
CA2609319C (en) 2005-07-15 2014-02-04 Nissan Chemical Industries, Ltd. Thiophene compounds and thrombopoietin receptor activators
KR101290484B1 (ko) 2005-07-20 2013-07-26 닛산 가가쿠 고교 가부시키 가이샤 피라졸 화합물 및 트롬보포이에틴 수용체 활성화제
US8093251B2 (en) 2006-06-07 2012-01-10 Nissan Chemical Industries, Ltd. Nitrogen-containing heterocyclic compounds and thrombopoietin receptor activators
JP5065974B2 (ja) * 2008-04-10 2012-11-07 株式会社船井電機新応用技術研究所 マイクロホンユニット及びその製造方法

Also Published As

Publication number Publication date
IL172374A (en) 2014-08-31
EP1636192B1 (en) 2014-01-15
JP5099089B2 (ja) 2012-12-12
PL1636192T3 (pl) 2014-05-30
EP1636192A1 (en) 2006-03-22
DK1636192T3 (en) 2014-03-03
AU2004245401B2 (en) 2009-11-12
JP2006527187A (ja) 2006-11-30
US20060094694A1 (en) 2006-05-04
US20130012708A1 (en) 2013-01-10
UA82695C2 (uk) 2008-05-12
JP4386072B2 (ja) 2009-12-16
HK1091809A1 (en) 2007-01-26
NO20054885L (no) 2005-12-28
NO334084B1 (no) 2013-12-09
US20110077290A1 (en) 2011-03-31
US8318796B2 (en) 2012-11-27
US7576115B2 (en) 2009-08-18
KR101211975B1 (ko) 2012-12-13
WO2004108683A1 (en) 2004-12-16
KR20060015729A (ko) 2006-02-20
TWI395739B (zh) 2013-05-11
US20080027068A1 (en) 2008-01-31
CA2520115A1 (en) 2004-12-16
US7351841B2 (en) 2008-04-01
PT1636192E (pt) 2014-02-11
AU2004245401A1 (en) 2004-12-16
JP2010006821A (ja) 2010-01-14
TW200510326A (en) 2005-03-16
CA2520115C (en) 2012-10-02
NZ542495A (en) 2009-01-31
MXPA05013209A (es) 2006-03-09
ES2445029T3 (es) 2014-02-27
US20140051857A1 (en) 2014-02-20
EP1636192B9 (en) 2015-07-01

Similar Documents

Publication Publication Date Title
NO20054885D0 (no) 3-alkylidenhydrazino substituerte heteroarylforbindelser som trombopoietin reseptor aktivator
DK1817309T3 (da) Acetamidforbindelser som fungicider
DK1638928T3 (da) N-alkynyl-2-(substituerede aryloxy)alkylthio-amidderivater som fungicider
DK1699797T3 (da) Pyrrolotriazinforbindelser som kinasehæmmere
CY2013044I2 (el) Δικυκλικες ετεροαρυλ ενωσεις
SE0301569D0 (sv) Novel compounds
ATE401328T1 (de) Verbrückte n-arylsulfonylpiperidine als gamma- sekretaseinhibitoren
DK1605897T3 (da) Polyethelen-glycol-link-glp-1-forbindelser
NL1031532A1 (nl) Nieuwe verbindingen van aminosulfonylderivaten.
ATE477257T1 (de) Piperidinylamino-thienoä2,3-dü- pyrimidinverbindungen
EP1689389A4 (en) INDOLE COMPOUNDS
IL183647A0 (en) 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
DK1585742T3 (da) Substituerede benzoylderivater som herbicider
DE602004014772D1 (de) Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors
DK1556377T3 (da) Cyclopropylthienylcarboxamider som fungicider
ATE404546T1 (de) Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen
DE502004001202D1 (de) Freilaufkupplung
IS8089A (is) Efnasambönd
ATE364601T1 (de) Substituierte pyrazolverbindungen
EP1631597A4 (en) SOLID PHASE CHEMICAL LIGATION CARRIED OUT WITH A MOBILE BONDING AGENT
DK1687263T3 (da) Cis-trans-isomerisering af semicarbazonforbindelser
NO20031736D0 (no) Forbindelser
ZA200509643B (en) 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators
NO20053911D0 (no) Diazepinderivater som er nyttige som LFA inhibitorer.
ZA200704979B (en) 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees